Mexico's Digital Health Boom: The New Frontier for Patient-Centric Care

LOS ANGELES, CA – September 03, 2026 – A quiet but powerful transformation is reshaping Latin America’s healthcare landscape, and Mexico is emerging as its epicenter. Fueled by a confluence of rising digital adoption, a young, tech-savvy populace, and a growing demand for more accessible care, the region is moving decisively away from episodic, location-based treatment toward connected, consumer-oriented models. Capturing this pivotal shift, El Poblado Investment Group has announced a deepened healthcare emphasis for its Fund III, underscored by a strategic investment in Omme, a Mexico-based digital men's health platform. The move is more than just a financial transaction; it's a barometer for the future of healthcare delivery in one of the world's most dynamic emerging markets.

Redesigning Healthcare for a Digital-First Mexico

The opportunity that El Poblado is seizing is rooted in a fundamental market evolution. The Latin American digital health market, valued at over $15 billion in 2025, is projected to grow at a staggering compound annual rate of over 20% through 2034. This explosive growth is not happening in a vacuum. It is being driven by a government actively promoting digital health—evidenced by Mexico’s January 2026 amendment to its General Health Law, which formally recognized “Digital Health”—and a patient population that is increasingly comfortable using technology for medical needs. A recent study found that nearly 66% of Mexican patients already use AI for health-related purposes, the highest rate in the region.

It is within this fertile ground that El Poblado is planting its flag. The firm is targeting companies that do more than just digitize existing processes. “We are looking for companies that are not simply digitizing healthcare, but redesigning the patient experience around trust, access, privacy, and better outcomes,” said Mason Mehta, Founder and General Partner of El Poblado Investment Group. This philosophy marks a strategic pivot toward ventures that can scale commercially while delivering tangible improvements in patient experience and community value.

Mexico presents a particularly compelling case. Its large population, growing private healthcare demand, and proximity to the United States create a unique environment for innovation. For El Poblado, the investment in Omme is a powerful example of its thesis in action—backing a company built to address specific, culturally-relevant gaps in the existing system.

The Omme Model: Aligning Incentives with Patient Outcomes

Omme is tackling what is often a silent epidemic: the under-treatment of chronic men's health conditions. Initially focused on hair loss and erectile dysfunction—conditions affecting over 30 million men in Mexico—the platform is built on a crucial insight. “Men in Mexico are far more likely to search for a health solution online than to walk into a clinic,” explained Elías Rivas, Founder and CEO of Omme. “That gap is not about awareness. It is about trust, stigma, and a system that was never designed around them.”

Traditional healthcare models often fail patients with chronic conditions not because treatments are unavailable, but because the system is not designed for sustained engagement. Physicians are paid for appointments, and pharmacies for prescriptions, irrespective of whether the patient remains adherent or sees results. Omme flips this model on its head. Its business incentives are directly aligned with patient success through prepaid six- and twelve-month medical programs.

From day one, each patient is paired with a board-certified specialist. The entire experience—from physician-led protocols and AI-powered follow-ups to continuous clinical support and discreet home delivery—is integrated into a single, structured journey. This isn't just telemedicine; it's a new infrastructure for chronic care management that prioritizes engagement and long-term outcomes. By aligning its revenue model with patient adherence, Omme aims to prove that “when you align the incentives of a business with the outcomes of its patients, both things get better,” as Rivas puts it. The company’s vision extends far beyond its initial focus, aiming to build a comprehensive platform for chronic men's healthcare across Latin America.

Beyond Capital: The Dual Strategy of Profit and Purpose

El Poblado's strategy in Latin America demonstrates an increasingly prevalent trend among sophisticated investors: the pursuit of a dual mandate of profit and purpose. The firm’s commercial investment in a high-growth disruptor like Omme is complemented by a deep-seated commitment to social impact, exemplified by its long-standing support for Fundación Vamos México.

Founded in 2001 by former Mexican President Vicente Fox and Marta Sahagún de Fox, the foundation supports vulnerable communities through a range of programs. El Poblado’s support is specifically directed toward CRISMA (Centro de Rehabilitación Integral San Miguel de Allende), a comprehensive rehabilitation center providing physical therapy, psychological care, and other specialized services to children and adults with physical and neurological disabilities, many of whom face significant financial barriers to care.

“El Poblado’s support of Fundación Vamos México reflects a meaningful commitment to health, dignity, and opportunity for the people of Mexico,” said President Vicente Fox. This philanthropic engagement illustrates how private capital can extend its impact beyond portfolio companies to strengthen foundational community institutions.

This commitment to “measurable community value” adds a layer of complexity. While Fundación Vamos México is accredited for its transparency and reports serving thousands of beneficiaries, it has also faced scrutiny from local media in Mexico regarding its financial practices and fund allocation. For an investor like El Poblado, navigating such associations requires a nuanced understanding of the local landscape, balancing the tangible good of programs like CRISMA with the reputational risks inherent in high-profile philanthropic partnerships.

Navigating the Landscape of a Nascent Market

While the opportunity in Latin America's digital health sector is undeniable, the path forward is not without its obstacles. The recent legal advancements in Mexico provide a foundational framework, but significant regulatory fragmentation remains. Innovators must still navigate a patchwork of state-level rules, a lack of standardized digital prescription systems, and an absence of clear reimbursement models from state insurers.

Furthermore, the digital divide persists. The promise of telemedicine and remote care can only be fully realized if reliable internet infrastructure reaches the rural and marginalized communities that stand to benefit most. For companies like Omme and investors like El Poblado, long-term success will depend not only on technological innovation and a patient-centric model but also on the ability to adeptly navigate this complex and evolving regulatory and infrastructural terrain. The investment in Omme is a clear bet that the tailwinds of digital adoption and consumer demand will ultimately overpower these structural headwinds, paving the way for a new era of healthcare in the region.